Potent Antiviral Therapy for Critically Ill HIV Infected Patients Admitted to Intensive Care [clinicaltrials:NCT00028327]
Potent Antiviral Therapy for Critically Ill HIV Infected Patients Admitted to Intensive Care [clinicaltrials:NCT00028327]
Bio2RDF identifier
NCT00028327
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00028327
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
Many HIV infected patie ...... ious illnesses or infections.
brief title [clinicaltrials_vocabulary:brief-title]
Potent Antiviral Therapy for C ...... nts Admitted to Intensive Care
condition [clinicaltrials_vocabulary:condition]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
There has been consider ...... eumocystis carinii pneumonia.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2001-12-20T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
AIDS-Related Opportunistic Infections
Antiretroviral Therapy, Highly Active
CD4 Lymphocyte Count
HIV Protease Inhibitors
Intensive Care Units
Lamivudine
Nelfinavir
Reverse Transcriptase Inhibitors
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2011-02-28T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00028327
official title [clinicaltrials_vocabulary:official-title]
Randomized Study to Evaluate I ...... Illness, Pneumonia, or Sepsis
org study id [clinicaltrials_vocabulary:org-study-id]
ACTG A5141
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2004-07-01T00:00:00Z
secondary id [clinicaltrials_vocabulary:secondary-id]
AACTG A5141
source [clinicaltrials_vocabulary:source]
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2004-07-01T00:00:00Z
identifier
clinicaltrials:NCT00028327
title
Potent Antiviral Therapy for C ...... nts Admitted to Intensive Care
@en
type
label
Potent Antiviral Therapy for C ...... e [clinicaltrials:NCT00028327]
@en